logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


20 New IPOs for Week of July 28

By  +Follow July 28, 2014 1:53PM
Share:
Tickers Mentioned:

Full IPO calendar & reports HERE.  In order of largest IPO first:

 

(1) Based in Stamford, CT, Synchrony Financial (SYF) scheduled a $3.06 billion IPO on the NYSE with a market capitalization of $20.3 billion at a price range midpoint of $24 for Thursday, July 31, 2014.

SYF is one of the premier consumer financial services companies in the United States. It's the old GE Capital.

 

(2) Based in Somerset, NJ, Catalent (CTLT) scheduled a $871 million IPO on the NYSE with a market capitalization of $2.4 billion at a price range midpoint of $20.50 for Thursday, July 31, 2014.

CTLT is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

 

(3) Based in Jerusalem, Israel, Mobileye N.V. (MBLY) scheduled a $500 million IPO on the NYSE with a market capitalization of $3.8 billion at a price range midpoint of $18 for Friday, August 1, 2014.

MBLY is the global leader in the design and development of software and related technologies for camera-based Advanced Driver Assistance Systems (“ADAS”).

 

(4) Based in London, United Kingdom, VTTI Energy Partners LP  (VTTI) scheduled a $350 million IPO on the NYSE, with a market capitalization of $402 million at a price range midpoint of $20 for Friday, August 1, 2014.

VTTI is a fee-based, growth-oriented limited partnership formed in April 2014 by VTTI, one of the world’s largest independent energy terminaling businesses, to own, operate, develop and acquire refined petroleum product and crude oil terminaling and related energy infrastructure assets on a global scale.

 

(5) Based in Aberdeen, United Kingdom,Transocean Partners (RIGP) scheduled a $350 million IPO on the NYSE with a market capitalization of $827 million at a price range midpoint of $20 for Thursday, July 31, 2014.

RIGP is a growth-oriented limited liability company recently formed by Transocean,one of the world’s largest offshore drilling contractors, to own, operate and acquire modern, technologically advanced offshore drilling rigs.

 

(6) Based in Houston, TX, Westlake Chemical Partners LP (WLKP) scheduled a $225 million IPO on the NYSE with a market capitalization of $508 milliion at a price range midpoint of $20 for Wednesday, July 30, 2014.

WLKP is a Delaware limited partnership recently formed by Westlake to operate, acquire and develop ethylene production facilities and related assets.

 

(7) Based in Weston, FL, FCB Financial Holdings (FCB) scheduled a $223 million IPO on the NYSE with a market capitalization of $1.02 billion at a price range midpoint of $25.50 for Friday, August 1, 2014.

 

(8) Based in Oakbrook Terrace, IL, SIRVA (SRVA) scheduled a $186 million IPO on the Nasdaq with a market capitalization of $632 million at a price range midpoint of $16 for Friday, August 1, 2014.

SRVA is a moving/relocation company.

 

(9) Based in North Billerica, MA, Lantheus Holdings (LNTH) scheduled a $125 million IPO on the Nasdaq with a market capitalization of $370 million at a price range midpoint of $13.50 for Wednesday, July 30, 2014.

LNTH is a global leader in developing, manufacturing, selling and distributing innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases.

 

(10) Based in Draper, UT, Health Equity (HQY) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $546 million at a price range midpoint of $11 for Thursday, July 31, 2014.

HQY is a leader and an innovator in the high growth category of technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions.

 

(11) Based in Or Yehuda, Israel, Vascular Biogenics (VBLX) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $259 million at a price range midpoint of $14 for Thursday, July 31, 2014.

VBLX is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

 

(12) Based in Menlo Park, CA, Avalanche Biotechnologies (AAVL) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $292 million at a price range midpoint of $14 for Thursday, July 31, 2014.

AAVL is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases.

 

(13) Based in Zug, Switzerland, Auris Medical Holding AG (EARS) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $283 million at a price range midpoint of $11 for Friday, August 1, 2014.

EARS is a clinical-stage biopharmaceutical company focused on the development of novel products for the treatment of inner ear disorders.

 

(14) Based in Petach Tikva, Israel, Macrocure (MCUR) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $264 million at a price range midpoint of $14 for Thursday, July 31, 2014.

MCUR is a regenerative medicine company focused on developing, manufacturing and commercializing novel cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds.

 

(15) Based in Fremont, CA, Zosano Pharma (ZSAN) scheduled a $70 million IPO on the Nasdaq with a market capitalization of $134 million at a price range midpoint of $11 for $134 million for the week of July 28th.

ZSAN is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications.

 

(16) Based in South San Francisco, CA, Tobira Therapeutics (TBRA) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $143 million at a price range midpoint of $13 for Thursday, July 31, 2014.

TBRA is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV, fibrosis and inflammation.

 

(17) Based in Stamford, CT, Loxo Oncology (LOXO) scheduled a $57 million IPO on the Nasdaq with a market capitalization of $196 million at a price range midpoint of $13 for Friday, August 1, 2014.

LOXO develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations.

 

(18) Based in New Haven, CT, Marinus Pharmaceuticals (MRNS) scheduled a $52 million IPO on the Nasdaq with a market capitalization of $159 million at a price range midpoint of $13 for Thursday, July 31, 2014.

MRNS is a clinical stage biopharmaceutical company focused on developing and commercializing innovative neuropsychiatric therapeutics.

 

(19) Based in Tel Aviv, Israel, Bio Blast Pharma Ltd. (ORPN) scheduled a $40 million IPO on the Nasdaq with a market capitalization of $172 million at a price range midpoint of $172 for Friday, Aug. 1, 2014.

ORPN is a development-stage biopharmaceutical company focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.

 

(20) Based in Yonker, NY, ContraFect (CFRXU) scheduled a $20 million IPO on the Nasdaq with a market capitalization of $96 million at a price range midpoint of $5.50 for Tuesday, July 29, 2014.

CFRXU is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for SYF
Jason Reno
31 Jul 15 12:49:00
How did @BillGriffeth keep a str8 face when Kelly asked $syf ceo,"How is cc biz still good?"
Livevol Community
31 Jul 15 09:00:04
HIGH PUT VOLU $TERP 1840% $KCG 1520% $CVC 1396% $YRCW 1062% $HBI 1056% $SYF 1039% $TNET 1024% $SYY 917% http://t.co/gwzPxh5Y4R
StockNewsWires
31 Jul 15 06:38:04
$SYF: New SEC Filing for SYF: Form 10-Q (No. 0001601712-15-000026): http://t.co/MiboyJangh
Latest SEC Filings
31 Jul 15 06:10:32
NEW SEC Filing for $SYF filed a moment ago: http://t.co/tLrkIbSaAQ http://t.co/xbO3a5IkT2
Capital Market Labs
30 Jul 15 15:30:01
Interactive Chart -> http://t.co/Uv9vCzS4Gr $SYF Revenue is Expanding. http://t.co/NEkR8VdmAq
StockNewsWires
30 Jul 15 12:57:02
$FEYE $SYF: Stocks Trader's Buzzers: Nokia Corporation (ADR) (NYSE:NOK ...: http://t.co/VEuxACc3u0
Capital Market Labs
30 Jul 15 11:54:15
Interactive Chart -> http://t.co/6m8bwHAqFa $SYF Return on Equity is Fading. http://t.co/NXdVxjo4Rk
ProVesting
29 Jul 15 22:17:02
$SYF: Zacks Rating on Synchrony Financial: http://t.co/oJ3GANzZof
John Ablemann
29 Jul 15 15:34:19
$SYF Margaret Keane: How Synchrony Financial Built A Winning Culture http://t.co/VkDB3TiCup
dailystockplays.com
29 Jul 15 15:08:56
MACD Bearish http://t.co/ZrqyG2riU7 $ESRX $QIHU $PTCT $FTSL $IPXL $USB $ENR $SYF $GRFS $AXDX $FFTY $OCUL $HMST $ANCX $SRNE $PRQR $MQY $EYES
Peter Bardens
29 Jul 15 14:13:55
$SYF Margaret Keane: How Synchrony Financial Built A Winning Culture http://t.co/T14SrasmZv
ProTradersNews
29 Jul 15 09:52:11
$SYF: Stock in Motion: Synchrony Financial (NYSE:SYF): http://t.co/SLVGAu3TIT
Capital Market Labs
29 Jul 15 07:55:13
Interactive Chart -> http://t.co/6m8bwHAqFa $SYF Return on Equity is Declining. http://t.co/7ur5qguCnM
Peter Bardens
29 Jul 15 07:03:26
$SYF Margaret Keane: How Synchrony Financial Built A Winning Culture http://t.co/UOqAp6yROj
Ticker Report
29 Jul 15 05:27:03
Synchrony Financial Assigned BBB Credit Rating by Morningstar $SYF http://t.co/3qN3yCCd1q
Dakota Financial
29 Jul 15 05:24:18
Synchrony Financial Assigned BBB Credit Rating by Morningstar $SYF http://t.co/0ge4cEp3FQ
Ticker Report
29 Jul 15 05:11:59
Synchrony Financial $SYF – Analysts’ Recent Ratings Updates http://t.co/zr6UUcteh4
Dakota Financial
29 Jul 15 05:09:15
Synchrony Financial $SYF – Analysts’ Recent Ratings Updates http://t.co/KqRrms9brL
InvestWithConf
28 Jul 15 18:31:02
$SYF is rated BUY, 12.5% upside by Wall Street analysts based on average ratings/targets http://t.co/ttC6Bz63H4 http://t.co/IoF8tJiM2M
Jarrad Fiorito
28 Jul 15 18:28:45
RT @ZorTrades: $SYF eps out of the way, reacted well to them, down 4 days in a row to 20day, wait for it to go green http://t.co/ybDd2ZjEpL
Frank Zorrilla
28 Jul 15 18:00:37
$SYF eps out of the way, reacted well to them, down 4 days in a row to 20day, wait for it to go green http://t.co/ybDd2ZjEpL
dailystockplays.com
28 Jul 15 15:03:38
Elder Red http://t.co/Jf122dR9WR $AES $ERIC $SRNE $ALU $CIEN $SYF $BLDR $NDAQ $OFG $WRB $DBD $ULTA $BNCL $CYNO $NAVB $BXP $BDE $XENT
Penny Stock Secret
28 Jul 15 10:49:38
$71,000 in ONE TRADE!! By Follwing Their Signals More Info Here http://t.co/SVqoMkrw2z .. $SYF $SYK $SYT
Shiraz Lakhi
28 Jul 15 10:39:44
Volume Spike Screener: FINANCIAL #Stocks Trading DOWN on STRONG Volume-Spike $COF $SYF $MHFI $RE ++ Full List Here: http://t.co/CnVlhzCKmA
DailyStockPicks
28 Jul 15 09:15:29
$OCLS cheap health care stock. Price target of $5. 200%+ upside $SYF $CTAS $TS $EGHT $WTM $HTGC investors read http://t.co/rWpJvFEbwZ
Peter Bardens
27 Jul 15 14:10:50
$SYF Margaret Keane: How Synchrony Financial Built A Winning Culture http://t.co/3CrTu1otXj
Vetr Ratings
27 Jul 15 10:42:32
Vetr users have upgraded Synchrony ... to a STRONG BUY Rating (4.5 stars), giving $SYF a target price of $39.00 http://t.co/ZgjoMFUJW2
ProTradersNews
27 Jul 15 05:44:03
$SYF: Consumers Consider Procedure and Costs Equally in Making ...: http://t.co/jYmcmFsdAA
Breaking News
27 Jul 15 05:35:02
$SYF: New SEC Filing for SYF: Form 8-K (No. 0001601712-15-000024): http://t.co/wRhrCswAN0
Latest SEC Filings
27 Jul 15 05:34:07
NEW SEC Filing for $SYF filed a moment ago: http://t.co/lsp2IaoldP http://t.co/MejyvabQFD
Judith Cole
26 Jul 15 08:34:45
Zacks Downgrades Synchrony Financial to Hold $SYF http://t.co/58RBtEPIOn via @RatingsNetwork
Breaking News
25 Jul 15 09:13:02
$SYF: Stamford Financial Services Firm Receives State Grant to Create ...: http://t.co/qMGBZCGWDT
Analyst Actions
24 Jul 15 17:23:01
$SYF: Analyst action by Keefe Bruyette & Woods on Synchrony Financial: http://t.co/RHunlL4IJR http://t.co/BmiL7NFiGq
Capital Market Labs
24 Jul 15 15:14:18
Interactive Chart -> http://t.co/Uv9vCA9FxZ $SYF Revenue is Growing. http://t.co/00B70DhSNs
FlashRatings
24 Jul 15 12:22:58
7 Best Analyst Rated Stocks This Week: $AMZN $HAL $AAPL $SWKS $SYF $P $YHOO View all ratings here: https://t.co/iU8lRcYMF2
The Legacy News
24 Jul 15 11:27:31
Zacks Downgrades Synchrony Financial to Hold $SYF http://t.co/ArgK3RlNDc
The Legacy News
24 Jul 15 09:28:44
Synchrony Financial Earns Buy Rating from Barclays $SYF http://t.co/KCj83fnZMo
BreakingStocksNews
24 Jul 15 05:33:02
$SYF: Confident Back-To-School Shoppers Still Look for Best Values ...: http://t.co/xzkMJ09zNL
FlashRatings
23 Jul 15 11:46:02
8 Best Analyst Rated Stocks in Last 7 Days: $GOOG $AMZN $GOOGL $HAL $SYF $AAPL $P $YHOO View all ratings here: https://t.co/iU8lRdgo3C
investor wired
23 Jul 15 09:14:01
Standout performers on a year-to-date basis: $EWBC $CS $SYF $FHN http://t.co/Ty0czwFgJ5
The Legacy News
23 Jul 15 07:28:25
BTIG Research Reaffirms Buy Rating for Synchrony Financial $SYF http://t.co/aqprplEz3s
				
				
By  +Follow July 28, 2014 1:53PM
Share:

Comments

 

blog comments powered by Disqus

 Today's Must Reads

Beyond Twitter: 5 Small-Cap Tech Plays Nobody’s Talking About


Will the Fed Continue Its Track Record of Unprecedented Moves?

Facebook versus Google: Who Rules the Internet?

Are These the Worst Business Documentaries on Netflix?


Saving the

Small-Cap Market

 

Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN